Notify me when Gavrilov Ognian Anguelov files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CLDI | Calidi Biotherapeutics, Inc. | Common Stock, $0.0001 par value | 9.8% | $532,000 | +$106,400 | 700,000 | +25% | Gavrilov Ognian Anguelov | 09 Mar 2026 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|